IEFM
NTLA icon

IQ EQ Fund Management’s Intellia Therapeutics NTLA Stock Holding History

IQ EQ Fund Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.29M Sell
724,286
-7,135
-1% -$90.9K 0.71% 41
2025
Q4 		$6.58M Buy
731,421
+236,953
+48% +$3.26M 0.45% 68
2025
Q3 		$8.54M Buy
494,468
+200,081
+68% +$2.46M 0.58% 54
2025
Q2 		$2.76M Buy
294,387
+188,178
+177% +$1.55M 0.25% 113
2025
Q1 		$755K Buy
106,209
+51,552
+94% +$521K 0.09% 211
2024
Q4 		$637K Buy
54,657
+31,626
+137% +$494K 0.08% 231
2024
Q3 		$473K Buy
23,031
+9,889
+75% +$228K 0.05% 264
2024
Q2 		$294K Buy
+13,142
New +$313K 0.03% 275

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return